

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 7.32724319 |
| 2 | cilium or flagellum-dependent cell motility (GO:0001539) | 7.09161051 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.26455809 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.26455809 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.75527333 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.75527333 |
| 7 | cilium movement (GO:0003341) | 5.73670281 |
| 8 | motile cilium assembly (GO:0044458) | 5.51943436 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.17306816 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.14862341 |
| 11 | epithelial cilium movement (GO:0003351) | 4.75879682 |
| 12 | central nervous system myelination (GO:0022010) | 4.68067032 |
| 13 | axon ensheathment in central nervous system (GO:0032291) | 4.68067032 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.31408902 |
| 15 | ethanol metabolic process (GO:0006067) | 4.28273286 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 4.21533075 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 4.21533075 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.21533075 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.13888920 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.09291655 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 4.06043574 |
| 22 | cysteine metabolic process (GO:0006534) | 4.02437900 |
| 23 | kynurenine metabolic process (GO:0070189) | 3.99346788 |
| 24 | glyoxylate metabolic process (GO:0046487) | 3.95403143 |
| 25 | tryptophan metabolic process (GO:0006568) | 3.91109101 |
| 26 | bile acid metabolic process (GO:0008206) | 3.82395146 |
| 27 | fatty acid elongation (GO:0030497) | 3.77120882 |
| 28 | urea metabolic process (GO:0019627) | 3.76972410 |
| 29 | urea cycle (GO:0000050) | 3.76972410 |
| 30 | coenzyme catabolic process (GO:0009109) | 3.72885651 |
| 31 | axoneme assembly (GO:0035082) | 3.61671097 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 3.61451055 |
| 33 | glutamate metabolic process (GO:0006536) | 3.57401833 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.54952795 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 3.53628573 |
| 36 | primary alcohol catabolic process (GO:0034310) | 3.50468759 |
| 37 | cellular modified amino acid catabolic process (GO:0042219) | 3.50428641 |
| 38 | tyrosine metabolic process (GO:0006570) | 3.50399282 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49251013 |
| 40 | epoxygenase P450 pathway (GO:0019373) | 3.48880075 |
| 41 | regulation of bile acid biosynthetic process (GO:0070857) | 3.47213595 |
| 42 | negative regulation of humoral immune response (GO:0002921) | 3.41996068 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.40463304 |
| 44 | protein carboxylation (GO:0018214) | 3.40463304 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 3.39320415 |
| 46 | drug catabolic process (GO:0042737) | 3.37286786 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.36065199 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.35191852 |
| 49 | short-chain fatty acid metabolic process (GO:0046459) | 3.34091564 |
| 50 | very long-chain fatty acid metabolic process (GO:0000038) | 3.30633241 |
| 51 | regulation of fibrinolysis (GO:0051917) | 3.29211988 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 3.27896341 |
| 53 | regulation of protein activation cascade (GO:2000257) | 3.27629957 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 3.25863645 |
| 55 | sperm capacitation (GO:0048240) | 3.25832292 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 3.25561744 |
| 57 | serine family amino acid catabolic process (GO:0009071) | 3.23611263 |
| 58 | homocysteine metabolic process (GO:0050667) | 3.22217664 |
| 59 | reverse cholesterol transport (GO:0043691) | 3.15971492 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 3.15945817 |
| 61 | acylglycerol homeostasis (GO:0055090) | 3.15354916 |
| 62 | triglyceride homeostasis (GO:0070328) | 3.15354916 |
| 63 | heme transport (GO:0015886) | 3.13924626 |
| 64 | cellular glucuronidation (GO:0052695) | 3.13117115 |
| 65 | regulation of cholesterol esterification (GO:0010872) | 3.11285922 |
| 66 | drug transmembrane transport (GO:0006855) | 3.10572076 |
| 67 | exogenous drug catabolic process (GO:0042738) | 3.10430895 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 3.10043238 |
| 69 | macromolecular complex remodeling (GO:0034367) | 3.10043238 |
| 70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.10043238 |
| 71 | regulation of complement activation (GO:0030449) | 3.04697199 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.01493685 |
| 73 | bile acid and bile salt transport (GO:0015721) | 3.00248294 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.99369666 |
| 75 | amine catabolic process (GO:0009310) | 2.98517043 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 2.98517043 |
| 77 | vitamin transmembrane transport (GO:0035461) | 2.96505708 |
| 78 | aspartate family amino acid catabolic process (GO:0009068) | 2.95853282 |
| 79 | lysine catabolic process (GO:0006554) | 2.94687341 |
| 80 | lysine metabolic process (GO:0006553) | 2.94687341 |
| 81 | ethanol oxidation (GO:0006069) | 2.94068135 |
| 82 | indolalkylamine metabolic process (GO:0006586) | 2.93621229 |
| 83 | negative regulation of sterol transport (GO:0032372) | 2.91795123 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 2.91795123 |
| 85 | response to methylmercury (GO:0051597) | 2.91561864 |
| 86 | cholesterol efflux (GO:0033344) | 2.91309018 |
| 87 | cofactor catabolic process (GO:0051187) | 2.89719923 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 2.87928377 |
| 89 | glucuronate metabolic process (GO:0019585) | 2.87713990 |
| 90 | uronic acid metabolic process (GO:0006063) | 2.87713990 |
| 91 | regulation of cholesterol homeostasis (GO:2000188) | 2.87099981 |
| 92 | negative regulation of lipase activity (GO:0060192) | 2.84363870 |
| 93 | ensheathment of neurons (GO:0007272) | 2.83352335 |
| 94 | axon ensheathment (GO:0008366) | 2.83352335 |
| 95 | ketone body metabolic process (GO:1902224) | 2.83220591 |
| 96 | myelination (GO:0042552) | 2.82673236 |
| 97 | drug metabolic process (GO:0017144) | 2.82339665 |
| 98 | carboxylic acid catabolic process (GO:0046395) | 2.81837913 |
| 99 | organic acid catabolic process (GO:0016054) | 2.81837913 |
| 100 | flavonoid metabolic process (GO:0009812) | 2.81271813 |
| 101 | benzene-containing compound metabolic process (GO:0042537) | 2.80559699 |
| 102 | diterpenoid biosynthetic process (GO:0016102) | 2.79496223 |
| 103 | gamma-aminobutyric acid transport (GO:0015812) | 2.79256001 |
| 104 | regulation of cilium movement (GO:0003352) | 2.77578655 |
| 105 | cholesterol homeostasis (GO:0042632) | 2.76785245 |
| 106 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.76608179 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 2.76263823 |
| 108 | dicarboxylic acid catabolic process (GO:0043649) | 2.72046437 |
| 109 | sterol homeostasis (GO:0055092) | 2.71821482 |
| 110 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.69271745 |
| 111 | negative regulation of protein activation cascade (GO:2000258) | 2.68874935 |
| 112 | phospholipid efflux (GO:0033700) | 2.67218704 |
| 113 | negative regulation of B cell mediated immunity (GO:0002713) | 2.66367313 |
| 114 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.66367313 |
| 115 | negative regulation of complement activation (GO:0045916) | 2.65957537 |
| 116 | iron coordination entity transport (GO:1901678) | 2.65047128 |
| 117 | serine family amino acid metabolic process (GO:0009069) | 2.64582547 |
| 118 | omega-hydroxylase P450 pathway (GO:0097267) | 2.64307265 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.63673272 |
| 120 | arginine metabolic process (GO:0006525) | 2.62346518 |
| 121 | primary alcohol metabolic process (GO:0034308) | 2.61641294 |
| 122 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.59831146 |
| 123 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.58666476 |
| 124 | quaternary ammonium group transport (GO:0015697) | 2.58108869 |
| 125 | macroautophagy (GO:0016236) | 2.53003468 |
| 126 | carnitine transport (GO:0015879) | 2.49527743 |
| 127 | amino-acid betaine transport (GO:0015838) | 2.49527743 |
| 128 | blood coagulation, intrinsic pathway (GO:0007597) | 2.49005734 |
| 129 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.47769506 |
| 130 | carnitine transmembrane transport (GO:1902603) | 2.46940265 |
| 131 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.44139105 |
| 132 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.43881925 |
| 133 | excretion (GO:0007588) | 2.43591574 |
| 134 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.42472563 |
| 135 | cellular response to ethanol (GO:0071361) | 2.40892196 |
| 136 | regulation of interleukin-13 production (GO:0032656) | 2.40680407 |
| 137 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.40227118 |
| 138 | sperm motility (GO:0030317) | 2.40145429 |
| 139 | regulation of humoral immune response (GO:0002920) | 2.36234854 |
| 140 | fibrinolysis (GO:0042730) | 2.36079404 |
| 141 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.35587704 |
| 142 | phospholipid homeostasis (GO:0055091) | 2.34853549 |
| 143 | carnitine metabolic process (GO:0009437) | 2.34163668 |
| 144 | ventricular system development (GO:0021591) | 2.33478972 |
| 145 | one-carbon compound transport (GO:0019755) | 2.31876284 |
| 146 | positive regulation of blood coagulation (GO:0030194) | 2.29590012 |
| 147 | positive regulation of hemostasis (GO:1900048) | 2.29590012 |
| 148 | regulation of germinal center formation (GO:0002634) | 2.28058485 |
| 149 | negative regulation of inclusion body assembly (GO:0090084) | 2.26876132 |
| 150 | protein activation cascade (GO:0072376) | 2.26096662 |
| 151 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.24002306 |
| 152 | positive regulation of coagulation (GO:0050820) | 2.23876772 |
| 153 | positive regulation of lipid catabolic process (GO:0050996) | 2.23764312 |
| 154 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.21758592 |
| 155 | microtubule bundle formation (GO:0001578) | 2.21297646 |
| 156 | retinol metabolic process (GO:0042572) | 2.20987559 |
| 157 | negative regulation of blood coagulation (GO:0030195) | 2.20356728 |
| 158 | negative regulation of hemostasis (GO:1900047) | 2.20356728 |
| 159 | sodium ion homeostasis (GO:0055078) | 2.16652991 |
| 160 | reactive oxygen species biosynthetic process (GO:1903409) | 2.15203393 |
| 161 | left/right pattern formation (GO:0060972) | 2.12376013 |
| 162 | left/right axis specification (GO:0070986) | 2.11783666 |
| 163 | multicellular organismal water homeostasis (GO:0050891) | 2.10728940 |
| 164 | iron ion import (GO:0097286) | 2.10574312 |
| 165 | glomerular epithelial cell development (GO:0072310) | 2.09749976 |
| 166 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.09216311 |
| 167 | phenylpropanoid metabolic process (GO:0009698) | 2.08376376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.11541545 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.79261035 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.29885560 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.99691274 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85640130 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61176103 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32234105 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.23882366 |
| 9 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.06736599 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05504018 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88930814 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83644837 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.83301370 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.82479653 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.73801276 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63936954 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63881321 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61979512 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61979512 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.60523747 |
| 21 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53175616 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52194427 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46850351 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46445208 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45935110 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.45319564 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44620242 |
| 28 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.44203224 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43603709 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43261661 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.41946755 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41246454 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41162429 |
| 34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40924558 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36190564 |
| 36 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36167177 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35795347 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32896411 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27352381 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26220488 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25876636 |
| 42 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25408652 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24328990 |
| 44 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22053587 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21331337 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20056843 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.20047802 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.19943619 |
| 49 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.19181383 |
| 50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18770814 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18553854 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16458048 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15795151 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15482661 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15435860 |
| 56 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15392746 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13887570 |
| 58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12342741 |
| 59 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11896539 |
| 60 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09948920 |
| 61 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.09902440 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09116203 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08513347 |
| 64 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07373526 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06397588 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05767386 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04300779 |
| 68 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03476019 |
| 69 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03160314 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02802688 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02371939 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02284310 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02167166 |
| 74 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.01343437 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01243595 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00710188 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99976979 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99399576 |
| 79 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99277761 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99276309 |
| 81 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99201401 |
| 82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99174807 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99126768 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99073094 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98339978 |
| 86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98301982 |
| 87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98036807 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97523495 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97523495 |
| 90 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97132034 |
| 91 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97036270 |
| 92 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96546092 |
| 93 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96365670 |
| 94 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96333004 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96200615 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96033721 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95034283 |
| 98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94282314 |
| 99 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92946441 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92880168 |
| 101 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92839066 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92347630 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92001058 |
| 104 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91301878 |
| 105 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.91297149 |
| 106 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.90870595 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90801479 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90352591 |
| 109 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90046831 |
| 110 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90036305 |
| 111 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89337463 |
| 112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89098684 |
| 113 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88994456 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88437845 |
| 115 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88057297 |
| 116 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87813961 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87801095 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87317652 |
| 119 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86986530 |
| 120 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86198113 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86176288 |
| 122 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86107174 |
| 123 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84543564 |
| 124 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83791883 |
| 125 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83651302 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83076444 |
| 127 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82854861 |
| 128 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82341306 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82319827 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82148314 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.81611737 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81369450 |
| 133 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.81068220 |
| 134 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80816330 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80490853 |
| 136 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79690205 |
| 137 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79450278 |
| 138 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79048933 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78857854 |
| 140 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78827228 |
| 141 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78749691 |
| 142 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78436321 |
| 143 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.77106383 |
| 144 | TCF4_23295773_ChIP-Seq_U87_Human | 0.76958625 |
| 145 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76887361 |
| 146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.76030002 |
| 147 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.75834070 |
| 148 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75539712 |
| 149 | * AR_19668381_ChIP-Seq_PC3_Human | 0.74089654 |
| 150 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73806711 |
| 151 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.73756522 |
| 152 | CJUN_26792858_Chip-Seq_BT549_Human | 0.73276966 |
| 153 | AR_25329375_ChIP-Seq_VCAP_Human | 0.73106657 |
| 154 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72649748 |
| 155 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.72455247 |
| 156 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.72394247 |
| 157 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72342061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.16947873 |
| 2 | MP0005360_urolithiasis | 5.68370264 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.64694998 |
| 4 | MP0005365_abnormal_bile_salt | 4.47819165 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.14267740 |
| 6 | MP0003252_abnormal_bile_duct | 3.07605406 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.68420184 |
| 8 | MP0005083_abnormal_biliary_tract | 2.48046317 |
| 9 | MP0005332_abnormal_amino_acid | 2.48041133 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.47605608 |
| 11 | MP0002132_abnormal_respiratory_system | 2.28357604 |
| 12 | MP0000920_abnormal_myelination | 2.27805470 |
| 13 | MP0003195_calcinosis | 2.24896366 |
| 14 | MP0003690_abnormal_glial_cell | 2.24633367 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.07161527 |
| 16 | MP0003880_abnormal_central_pattern | 2.03660732 |
| 17 | MP0009840_abnormal_foam_cell | 1.98313148 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 1.97308607 |
| 19 | MP0004270_analgesia | 1.94496280 |
| 20 | MP0003329_amyloid_beta_deposits | 1.91706702 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.83687532 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.81579956 |
| 23 | MP0004043_abnormal_pH_regulation | 1.79745115 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.78004894 |
| 25 | MP0004885_abnormal_endolymph | 1.76756636 |
| 26 | MP0002653_abnormal_ependyma_morphology | 1.74374213 |
| 27 | MP0003879_abnormal_hair_cell | 1.74256647 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.73685049 |
| 29 | MP0005410_abnormal_fertilization | 1.69698608 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.67892132 |
| 31 | MP0003724_increased_susceptibility_to | 1.61394178 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.61276268 |
| 33 | MP0001486_abnormal_startle_reflex | 1.60414341 |
| 34 | MP0003045_fibrosis | 1.56066732 |
| 35 | MP0002168_other_aberrant_phenotype | 1.55233809 |
| 36 | MP0002822_catalepsy | 1.55055669 |
| 37 | MP0009046_muscle_twitch | 1.50560598 |
| 38 | MP0005310_abnormal_salivary_gland | 1.48442671 |
| 39 | MP0003868_abnormal_feces_composition | 1.46235210 |
| 40 | MP0003303_peritoneal_inflammation | 1.45998430 |
| 41 | MP0005451_abnormal_body_composition | 1.43711257 |
| 42 | MP0008004_abnormal_stomach_pH | 1.43602191 |
| 43 | MP0002064_seizures | 1.42382425 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.37934109 |
| 45 | MP0002272_abnormal_nervous_system | 1.37540128 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.37441518 |
| 47 | MP0003866_abnormal_defecation | 1.35306377 |
| 48 | MP0009745_abnormal_behavioral_response | 1.34648508 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.34280857 |
| 50 | MP0000604_amyloidosis | 1.31856845 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29092684 |
| 52 | MP0001756_abnormal_urination | 1.28687039 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.25433511 |
| 54 | MP0003878_abnormal_ear_physiology | 1.25433511 |
| 55 | MP0000609_abnormal_liver_physiology | 1.22519964 |
| 56 | MP0005409_darkened_coat_color | 1.20930066 |
| 57 | MP0002254_reproductive_system_inflammat | 1.19701158 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.18741092 |
| 59 | MP0003011_delayed_dark_adaptation | 1.14971416 |
| 60 | MP0004130_abnormal_muscle_cell | 1.14457602 |
| 61 | MP0000566_synostosis | 1.10797317 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.10706627 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.10330264 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.10256936 |
| 65 | MP0004883_abnormal_blood_vessel | 1.08907544 |
| 66 | MP0004142_abnormal_muscle_tone | 1.08148817 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.07714642 |
| 68 | MP0002136_abnormal_kidney_physiology | 1.06972634 |
| 69 | MP0002909_abnormal_adrenal_gland | 1.06295160 |
| 70 | MP0003632_abnormal_nervous_system | 1.04879526 |
| 71 | MP0005164_abnormal_response_to | 1.04694499 |
| 72 | MP0001440_abnormal_grooming_behavior | 1.04372735 |
| 73 | MP0002229_neurodegeneration | 1.01850839 |
| 74 | MP0005387_immune_system_phenotype | 1.01728167 |
| 75 | MP0001790_abnormal_immune_system | 1.01728167 |
| 76 | MP0005166_decreased_susceptibility_to | 1.00980955 |
| 77 | MP0003300_gastrointestinal_ulcer | 1.00874758 |
| 78 | MP0002572_abnormal_emotion/affect_behav | 1.00837504 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.98659597 |
| 80 | MP0010386_abnormal_urinary_bladder | 0.98582984 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.97330244 |
| 82 | MP0002063_abnormal_learning/memory/cond | 0.96358954 |
| 83 | MP0009115_abnormal_fat_cell | 0.95019568 |
| 84 | MP0003633_abnormal_nervous_system | 0.94706288 |
| 85 | MP0001984_abnormal_olfaction | 0.94162334 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.93746646 |
| 87 | MP0004381_abnormal_hair_follicle | 0.92554701 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.91049544 |
| 89 | MP0009780_abnormal_chondrocyte_physiolo | 0.90054552 |
| 90 | MP0003634_abnormal_glial_cell | 0.89962979 |
| 91 | MP0000249_abnormal_blood_vessel | 0.89346538 |
| 92 | MP0002734_abnormal_mechanical_nocicepti | 0.89259888 |
| 93 | MP0004742_abnormal_vestibular_system | 0.89135560 |
| 94 | MP0003631_nervous_system_phenotype | 0.88485721 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.85272906 |
| 96 | MP0005025_abnormal_response_to | 0.85161645 |
| 97 | MP0001664_abnormal_digestion | 0.84976217 |
| 98 | MP0005647_abnormal_sex_gland | 0.84930744 |
| 99 | MP0000579_abnormal_nail_morphology | 0.84800942 |
| 100 | MP0001800_abnormal_humoral_immune | 0.84184354 |
| 101 | MP0001663_abnormal_digestive_system | 0.83764173 |
| 102 | MP0001661_extended_life_span | 0.83257217 |
| 103 | MP0004484_altered_response_of | 0.82022033 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.81742456 |
| 105 | MP0000778_abnormal_nervous_system | 0.80273814 |
| 106 | MP0008872_abnormal_physiological_respon | 0.80232891 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.79236849 |
| 108 | MP0004947_skin_inflammation | 0.78843213 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.78701203 |
| 110 | MP0009785_altered_susceptibility_to | 0.78648778 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.78044768 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.77522156 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.77424851 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.77248223 |
| 115 | MP0005535_abnormal_body_temperature | 0.76482443 |
| 116 | MP0008874_decreased_physiological_sensi | 0.75957259 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.75684028 |
| 118 | MP0003950_abnormal_plasma_membrane | 0.75419963 |
| 119 | MP0000462_abnormal_digestive_system | 0.75120482 |
| 120 | MP0002067_abnormal_sensory_capabilities | 0.73889987 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.73725520 |
| 122 | MP0004510_myositis | 0.73559623 |
| 123 | MP0001177_atelectasis | 0.72447832 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.72348010 |
| 125 | MP0005395_other_phenotype | 0.72087743 |
| 126 | MP0005448_abnormal_energy_balance | 0.71828114 |
| 127 | MP0005423_abnormal_somatic_nervous | 0.71396751 |
| 128 | MP0002277_abnormal_respiratory_mucosa | 0.71306999 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.71090063 |
| 130 | MP0003172_abnormal_lysosome_physiology | 0.71014886 |
| 131 | MP0002419_abnormal_innate_immunity | 0.70886200 |
| 132 | MP0003075_altered_response_to | 0.69378552 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.69363725 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.69131075 |
| 135 | MP0005636_abnormal_mineral_homeostasis | 0.68720828 |
| 136 | MP0001764_abnormal_homeostasis | 0.68645985 |
| 137 | MP0000955_abnormal_spinal_cord | 0.68298353 |
| 138 | MP0002066_abnormal_motor_capabilities/c | 0.66876924 |
| 139 | MP0001905_abnormal_dopamine_level | 0.66596181 |
| 140 | MP0005670_abnormal_white_adipose | 0.65568939 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.64995721 |
| 142 | MP0005084_abnormal_gallbladder_morpholo | 0.63507851 |
| 143 | MP0002971_abnormal_brown_adipose | 0.63360882 |
| 144 | MP0008569_lethality_at_weaning | 0.61839874 |
| 145 | MP0001502_abnormal_circadian_rhythm | 0.60645079 |
| 146 | MP0005408_hypopigmentation | 0.59865560 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.59191597 |
| 148 | MP0005386_behavior/neurological_phenoty | 0.59139327 |
| 149 | MP0004924_abnormal_behavior | 0.59139327 |
| 150 | MP0001346_abnormal_lacrimal_gland | 0.58325341 |
| 151 | MP0000639_abnormal_adrenal_gland | 0.58145275 |
| 152 | MP0002882_abnormal_neuron_morphology | 0.56541928 |
| 153 | MP0003656_abnormal_erythrocyte_physiolo | 0.55973361 |
| 154 | MP0002069_abnormal_eating/drinking_beha | 0.55185408 |
| 155 | MP0000383_abnormal_hair_follicle | 0.54175837 |
| 156 | MP0009384_cardiac_valve_regurgitation | 0.54044133 |
| 157 | MP0004858_abnormal_nervous_system | 0.53535351 |
| 158 | MP0002733_abnormal_thermal_nociception | 0.51930131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.48536500 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 7.06851453 |
| 3 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 7.06851453 |
| 4 | Abnormal ciliary motility (HP:0012262) | 6.92894971 |
| 5 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.81835873 |
| 6 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.81835873 |
| 7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.76895313 |
| 8 | Rhinitis (HP:0012384) | 6.06519608 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.82623487 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.75635968 |
| 11 | Deep venous thrombosis (HP:0002625) | 5.35542660 |
| 12 | Chronic bronchitis (HP:0004469) | 4.91017757 |
| 13 | Bronchiectasis (HP:0002110) | 4.81929440 |
| 14 | Xanthomatosis (HP:0000991) | 4.59505413 |
| 15 | Hyperactive renin-angiotensin system (HP:0000841) | 4.58600186 |
| 16 | Nasal polyposis (HP:0100582) | 4.52100437 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.49820077 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 4.40919482 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 4.39458755 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.98282323 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.75594144 |
| 22 | Abnormality of the nasal mucosa (HP:0000433) | 3.74247186 |
| 23 | Complement deficiency (HP:0004431) | 3.52723146 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.46281128 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.46281128 |
| 26 | Recurrent sinusitis (HP:0011108) | 3.46141976 |
| 27 | Hyperglycinemia (HP:0002154) | 3.38147779 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.36315776 |
| 29 | Hyperammonemia (HP:0001987) | 3.34969443 |
| 30 | Ketosis (HP:0001946) | 3.30719557 |
| 31 | Epidermoid cyst (HP:0200040) | 3.30052418 |
| 32 | Infertility (HP:0000789) | 3.27453634 |
| 33 | Hyperglycinuria (HP:0003108) | 3.27181359 |
| 34 | Bronchitis (HP:0012387) | 3.26995680 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.26096413 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.12204810 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.11802330 |
| 38 | Fat malabsorption (HP:0002630) | 3.11690120 |
| 39 | Abnormality of chloride homeostasis (HP:0011422) | 3.11195564 |
| 40 | Joint hemorrhage (HP:0005261) | 3.05784956 |
| 41 | Hypolipoproteinemia (HP:0010981) | 3.01813855 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.95776226 |
| 43 | Male infertility (HP:0003251) | 2.94643645 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.92980843 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.92704490 |
| 46 | Hyperkalemia (HP:0002153) | 2.92285508 |
| 47 | Hyperventilation (HP:0002883) | 2.89411493 |
| 48 | Recurrent otitis media (HP:0000403) | 2.87635165 |
| 49 | Chronic sinusitis (HP:0011109) | 2.86854791 |
| 50 | Abnormality of the corticospinal tract (HP:0002492) | 2.83118104 |
| 51 | Confusion (HP:0001289) | 2.80736280 |
| 52 | Menorrhagia (HP:0000132) | 2.79681481 |
| 53 | Abnormality of renin-angiotensin system (HP:0000847) | 2.79559210 |
| 54 | Gout (HP:0001997) | 2.79199702 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.79119892 |
| 56 | Hyperaldosteronism (HP:0000859) | 2.78897041 |
| 57 | Sensory axonal neuropathy (HP:0003390) | 2.78109476 |
| 58 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.73086571 |
| 59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.73086571 |
| 60 | Intention tremor (HP:0002080) | 2.70536467 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.68626395 |
| 62 | Vascular calcification (HP:0004934) | 2.68339529 |
| 63 | Decreased circulating renin level (HP:0003351) | 2.64244610 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.61034180 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.59423076 |
| 66 | Purpura (HP:0000979) | 2.58138329 |
| 67 | Myokymia (HP:0002411) | 2.50453604 |
| 68 | Spastic tetraparesis (HP:0001285) | 2.48561992 |
| 69 | Tubulointerstitial nephritis (HP:0001970) | 2.45254841 |
| 70 | Hypochromic microcytic anemia (HP:0004840) | 2.44787254 |
| 71 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43509295 |
| 72 | Steatorrhea (HP:0002570) | 2.41916521 |
| 73 | Renal salt wasting (HP:0000127) | 2.38418682 |
| 74 | Alkalosis (HP:0001948) | 2.36899003 |
| 75 | Gingival bleeding (HP:0000225) | 2.36824387 |
| 76 | Glomerulonephritis (HP:0000099) | 2.35785356 |
| 77 | Chronic otitis media (HP:0000389) | 2.35781149 |
| 78 | Increased circulating renin level (HP:0000848) | 2.35525854 |
| 79 | Amyloidosis (HP:0011034) | 2.35422085 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34285297 |
| 81 | Dysmetria (HP:0001310) | 2.33581655 |
| 82 | Metabolic alkalosis (HP:0200114) | 2.32330873 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.31642786 |
| 84 | Ketoacidosis (HP:0001993) | 2.30204839 |
| 85 | Hypophosphatemic rickets (HP:0004912) | 2.29063421 |
| 86 | Chronic hepatic failure (HP:0100626) | 2.27878795 |
| 87 | Enlarged kidneys (HP:0000105) | 2.27820129 |
| 88 | Scanning speech (HP:0002168) | 2.25614334 |
| 89 | Abnormality of complement system (HP:0005339) | 2.25446680 |
| 90 | Spastic gait (HP:0002064) | 2.24561978 |
| 91 | Abnormality of purine metabolism (HP:0004352) | 2.23433108 |
| 92 | Rickets (HP:0002748) | 2.23308112 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.18898602 |
| 94 | Metabolic acidosis (HP:0001942) | 2.15660099 |
| 95 | Status epilepticus (HP:0002133) | 2.15439276 |
| 96 | Recurrent bronchitis (HP:0002837) | 2.14230501 |
| 97 | Flat acetabular roof (HP:0003180) | 2.13000314 |
| 98 | Abnormality of the intrinsic pathway (HP:0010989) | 2.12585415 |
| 99 | Turricephaly (HP:0000262) | 2.11913897 |
| 100 | Focal motor seizures (HP:0011153) | 2.09136829 |
| 101 | Cholecystitis (HP:0001082) | 2.07981681 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 2.07981681 |
| 103 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07222411 |
| 104 | Hyperbilirubinemia (HP:0002904) | 2.06959810 |
| 105 | Nephritis (HP:0000123) | 2.06690583 |
| 106 | Abnormality of serum amino acid levels (HP:0003112) | 2.03900268 |
| 107 | Onion bulb formation (HP:0003383) | 2.03611607 |
| 108 | Potter facies (HP:0002009) | 2.03579913 |
| 109 | Facial shape deformation (HP:0011334) | 2.03579913 |
| 110 | Supranuclear gaze palsy (HP:0000605) | 2.03113611 |
| 111 | Abnormality of nucleobase metabolism (HP:0010932) | 2.03049428 |
| 112 | Hypoglycemic coma (HP:0001325) | 2.01769150 |
| 113 | Spastic paraparesis (HP:0002313) | 2.01575402 |
| 114 | Skin nodule (HP:0200036) | 2.00790593 |
| 115 | Epistaxis (HP:0000421) | 1.99579633 |
| 116 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.99080899 |
| 117 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.98219769 |
| 118 | Aplasia of the phalanges of the hand (HP:0009802) | 1.98219769 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 1.98219769 |
| 120 | Hypokalemic alkalosis (HP:0001949) | 1.97811384 |
| 121 | Irritability (HP:0000737) | 1.95890563 |
| 122 | Abnormality of renal excretion (HP:0011036) | 1.94852870 |
| 123 | Hyperuricemia (HP:0002149) | 1.93382967 |
| 124 | Increased purine levels (HP:0004368) | 1.93382967 |
| 125 | Malnutrition (HP:0004395) | 1.93133567 |
| 126 | Abnormality of vitamin metabolism (HP:0100508) | 1.91069921 |
| 127 | Tubular atrophy (HP:0000092) | 1.90418534 |
| 128 | Spontaneous abortion (HP:0005268) | 1.90365801 |
| 129 | Abnormality of potassium homeostasis (HP:0011042) | 1.90320643 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89524110 |
| 131 | Synostosis involving the elbow (HP:0003938) | 1.87981434 |
| 132 | Humeroradial synostosis (HP:0003041) | 1.87981434 |
| 133 | Cystic liver disease (HP:0006706) | 1.86229732 |
| 134 | Cone-rod dystrophy (HP:0000548) | 1.84273130 |
| 135 | Infantile muscular hypotonia (HP:0008947) | 1.84153074 |
| 136 | Coronal craniosynostosis (HP:0004440) | 1.82225120 |
| 137 | Action tremor (HP:0002345) | 1.81043423 |
| 138 | Occipital encephalocele (HP:0002085) | 1.80890224 |
| 139 | Abnormal gallbladder morphology (HP:0012437) | 1.80491842 |
| 140 | Lethargy (HP:0001254) | 1.80277841 |
| 141 | Bifid scrotum (HP:0000048) | 1.73604416 |
| 142 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.73125102 |
| 143 | Bell-shaped thorax (HP:0001591) | 1.71485973 |
| 144 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.71394365 |
| 145 | Dicarboxylic aciduria (HP:0003215) | 1.71394365 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.70160197 |
| 147 | Hypoglycemic seizures (HP:0002173) | 1.69356517 |
| 148 | Generalized myoclonic seizures (HP:0002123) | 1.68518583 |
| 149 | Abnormal urine output (HP:0012590) | 1.65303896 |
| 150 | Portal hypertension (HP:0001409) | 1.64762738 |
| 151 | Mitral stenosis (HP:0001718) | 1.64556447 |
| 152 | Increased mean platelet volume (HP:0011877) | 1.63878143 |
| 153 | Amelogenesis imperfecta (HP:0000705) | 1.63394254 |
| 154 | Decreased central vision (HP:0007663) | 1.62219024 |
| 155 | Hypokalemia (HP:0002900) | 1.61178594 |
| 156 | True hermaphroditism (HP:0010459) | 1.61124563 |
| 157 | Abnormality of the renal medulla (HP:0100957) | 1.60363400 |
| 158 | Adrenal overactivity (HP:0002717) | 1.59523383 |
| 159 | Ventricular fibrillation (HP:0001663) | 1.58771681 |
| 160 | Abnormal platelet volume (HP:0011876) | 1.58065657 |
| 161 | Abnormal drinking behavior (HP:0030082) | 1.57436442 |
| 162 | Polydipsia (HP:0001959) | 1.57436442 |
| 163 | Progressive cerebellar ataxia (HP:0002073) | 1.57218867 |
| 164 | Right ventricular cardiomyopathy (HP:0011663) | 1.56228906 |
| 165 | Obstructive sleep apnea (HP:0002870) | 1.55537848 |
| 166 | Hyponatremia (HP:0002902) | 1.55093374 |
| 167 | Pancreatic cysts (HP:0001737) | 1.53270200 |
| 168 | Stage 5 chronic kidney disease (HP:0003774) | 1.51483208 |
| 169 | Abnormality of the hepatic vasculature (HP:0006707) | 1.48694286 |
| 170 | Recurrent pneumonia (HP:0006532) | 1.48597501 |
| 171 | Atelectasis (HP:0100750) | 1.48154133 |
| 172 | Bronchomalacia (HP:0002780) | 1.46205172 |
| 173 | Petechiae (HP:0000967) | 1.45459127 |
| 174 | Increased cerebral lipofuscin (HP:0011813) | 1.42263384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.34170141 |
| 2 | OXSR1 | 3.82855490 |
| 3 | EPHA2 | 3.42637299 |
| 4 | RIPK4 | 3.10372648 |
| 5 | MST4 | 3.00615213 |
| 6 | EPHA4 | 2.72497090 |
| 7 | WNK4 | 2.51637548 |
| 8 | EPHB1 | 2.41584680 |
| 9 | TNIK | 2.41307659 |
| 10 | FGFR2 | 2.33599173 |
| 11 | FRK | 2.17146643 |
| 12 | WNK1 | 2.06631687 |
| 13 | BLK | 2.01326423 |
| 14 | BCKDK | 1.93307355 |
| 15 | ICK | 1.90089326 |
| 16 | SIK1 | 1.89263336 |
| 17 | NTRK1 | 1.81670842 |
| 18 | PKN1 | 1.74138763 |
| 19 | MET | 1.73891672 |
| 20 | NTRK3 | 1.72692807 |
| 21 | INSRR | 1.71353299 |
| 22 | MAPKAPK3 | 1.70101212 |
| 23 | TRIB3 | 1.65164869 |
| 24 | ERBB4 | 1.63548756 |
| 25 | PRPF4B | 1.57501081 |
| 26 | MAP3K3 | 1.57091938 |
| 27 | PIK3CA | 1.49744906 |
| 28 | MAP2K4 | 1.45136465 |
| 29 | TNK2 | 1.44813164 |
| 30 | PAK6 | 1.40097156 |
| 31 | TYRO3 | 1.37167384 |
| 32 | BCR | 1.37095879 |
| 33 | SGK494 | 1.36817981 |
| 34 | SGK223 | 1.36817981 |
| 35 | CDK19 | 1.34281534 |
| 36 | DAPK2 | 1.32402331 |
| 37 | NEK6 | 1.30392170 |
| 38 | STK24 | 1.25966707 |
| 39 | CAMK2B | 1.24087888 |
| 40 | ACVR1B | 1.21403470 |
| 41 | RIPK1 | 1.19695235 |
| 42 | CAMK2G | 1.18778703 |
| 43 | CSK | 1.18128348 |
| 44 | PAK3 | 1.16951237 |
| 45 | MAP3K7 | 1.13335510 |
| 46 | PIK3CG | 1.11403376 |
| 47 | CDK12 | 1.08362477 |
| 48 | FGFR4 | 1.07783931 |
| 49 | PNCK | 1.07205937 |
| 50 | STK38L | 1.06507952 |
| 51 | MST1R | 1.06363751 |
| 52 | NTRK2 | 1.06184943 |
| 53 | GRK5 | 1.06091045 |
| 54 | BMPR2 | 1.04668450 |
| 55 | CAMK1G | 1.01235006 |
| 56 | MARK2 | 1.01097357 |
| 57 | PINK1 | 0.99456360 |
| 58 | EPHA3 | 0.98856541 |
| 59 | BTK | 0.98297476 |
| 60 | MAPK15 | 0.97841002 |
| 61 | CSNK1A1L | 0.96601990 |
| 62 | TRPM7 | 0.95542800 |
| 63 | PRKD3 | 0.94671678 |
| 64 | ZAP70 | 0.94510576 |
| 65 | FGFR3 | 0.94391029 |
| 66 | MYLK | 0.94353399 |
| 67 | CAMK2D | 0.93641648 |
| 68 | PDPK1 | 0.93049425 |
| 69 | CSNK1G2 | 0.91663429 |
| 70 | STK38 | 0.91226562 |
| 71 | MAP3K12 | 0.89929111 |
| 72 | TYK2 | 0.88233419 |
| 73 | MAPK7 | 0.88084870 |
| 74 | FGR | 0.87477152 |
| 75 | CSF1R | 0.86496550 |
| 76 | CDK5 | 0.85834741 |
| 77 | JAK1 | 0.85791760 |
| 78 | ERN1 | 0.85562380 |
| 79 | CDC42BPA | 0.85493631 |
| 80 | AKT3 | 0.85480815 |
| 81 | RET | 0.82974134 |
| 82 | GRK1 | 0.82081679 |
| 83 | CAMK2A | 0.81541347 |
| 84 | PKN2 | 0.80624033 |
| 85 | PBK | 0.80021033 |
| 86 | TAOK1 | 0.80017917 |
| 87 | IRAK1 | 0.79793083 |
| 88 | CASK | 0.78556735 |
| 89 | MARK1 | 0.78122078 |
| 90 | CSNK1G3 | 0.77057651 |
| 91 | PRKCQ | 0.76702437 |
| 92 | CSNK1G1 | 0.75806259 |
| 93 | MAP3K13 | 0.75391937 |
| 94 | MAP3K4 | 0.75233366 |
| 95 | MAP3K1 | 0.74761878 |
| 96 | ERBB2 | 0.74404893 |
| 97 | PRKCG | 0.73592153 |
| 98 | NLK | 0.69853285 |
| 99 | MAP3K9 | 0.68895885 |
| 100 | PHKG2 | 0.68514864 |
| 101 | PHKG1 | 0.68514864 |
| 102 | PRKCH | 0.68315480 |
| 103 | WNK3 | 0.66896902 |
| 104 | UHMK1 | 0.65964084 |
| 105 | PDK1 | 0.65575866 |
| 106 | STK11 | 0.63819787 |
| 107 | CAMKK1 | 0.63778603 |
| 108 | PDGFRB | 0.62572868 |
| 109 | PRKCZ | 0.62346082 |
| 110 | MAP3K2 | 0.62337941 |
| 111 | SYK | 0.62193207 |
| 112 | SGK3 | 0.61841114 |
| 113 | EEF2K | 0.61593814 |
| 114 | MAPKAPK5 | 0.59920794 |
| 115 | ADRBK2 | 0.58913109 |
| 116 | BMX | 0.58825171 |
| 117 | ROCK2 | 0.58801188 |
| 118 | PRKAA2 | 0.58463945 |
| 119 | GRK6 | 0.58400540 |
| 120 | CHUK | 0.58370801 |
| 121 | KSR2 | 0.57918743 |
| 122 | MAP3K6 | 0.56769253 |
| 123 | PTK2 | 0.56404267 |
| 124 | MAP2K6 | 0.56343098 |
| 125 | DDR2 | 0.55196193 |
| 126 | PRKCE | 0.53968536 |
| 127 | TAOK3 | 0.53266597 |
| 128 | IRAK2 | 0.52698626 |
| 129 | PTK2B | 0.51322395 |
| 130 | PRKD1 | 0.51209767 |
| 131 | MATK | 0.50506927 |
| 132 | CAMK1 | 0.50429592 |
| 133 | TESK1 | 0.50366724 |
| 134 | HIPK2 | 0.50078682 |
| 135 | GSK3A | 0.49381124 |
| 136 | TBK1 | 0.49338269 |
| 137 | FYN | 0.48696987 |
| 138 | IKBKE | 0.47477197 |
| 139 | LATS1 | 0.47462104 |
| 140 | SGK2 | 0.46572351 |
| 141 | MINK1 | 0.46195159 |
| 142 | JAK2 | 0.45652050 |
| 143 | IKBKB | 0.45563926 |
| 144 | PRKAA1 | 0.45472970 |
| 145 | SGK1 | 0.45132976 |
| 146 | YES1 | 0.44097671 |
| 147 | PRKACG | 0.43938466 |
| 148 | MAPK11 | 0.43544918 |
| 149 | PTK6 | 0.43064808 |
| 150 | PRKACB | 0.40956455 |
| 151 | CDK15 | 0.40881005 |
| 152 | CAMK1D | 0.40649049 |
| 153 | RPS6KA3 | 0.40334787 |
| 154 | FER | 0.39927289 |
| 155 | CAMK4 | 0.39208322 |
| 156 | MAP2K7 | 0.39140368 |
| 157 | LMTK2 | 0.38620125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.94294430 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.53650936 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68603630 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.62366969 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46716279 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29390135 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23761144 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.22249406 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16229219 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12709851 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02835779 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.00654726 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97000654 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96346483 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.94544266 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90524497 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90123559 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81520480 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.78452408 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.77965979 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.77442576 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76768822 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75024675 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75007937 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.74610063 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73020881 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72630877 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69047838 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60215121 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57950874 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.53667482 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51909127 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49456326 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41863790 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.18480430 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13618624 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12131984 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11770855 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11607633 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06886993 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06269662 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03950988 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03599170 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01657471 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99955069 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99692638 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97884651 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94742245 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92437779 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87649681 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 0.81599781 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81132648 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79871524 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.79128132 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78168322 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77941743 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77159667 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77072485 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76454754 |
| 60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.76315353 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74839518 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74327898 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73333738 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70884655 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70615745 |
| 66 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68079216 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.68064522 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67395613 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65131954 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64603864 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63753168 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62906846 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61390393 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60758468 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60456641 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.60165253 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58242069 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57754059 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.56952362 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56228277 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.55844660 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54733180 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51037772 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48819327 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47849288 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.47772763 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47230717 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44977824 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44926299 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44391204 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44325796 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44105865 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.44069984 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.43713120 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42327596 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42065039 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.42060981 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40424231 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40265404 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.39119668 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39069462 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37292043 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36865687 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.34946669 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34945832 |
| 106 | Tuberculosis_Homo sapiens_hsa05152 | 0.33331845 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33014778 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32818573 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32638395 |
| 110 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32576233 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32391981 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32343356 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31982215 |
| 114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31386509 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31349940 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31348742 |
| 117 | Axon guidance_Homo sapiens_hsa04360 | 0.31179880 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30956054 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.30610366 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.29817082 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.29653502 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.29033029 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.28568251 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27729434 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.27680390 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.27481661 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26864496 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26863237 |
| 129 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.26680744 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25373146 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.24668065 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22650574 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21752053 |
| 134 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20597828 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.20244572 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20187544 |
| 137 | Insulin secretion_Homo sapiens_hsa04911 | 0.19728205 |
| 138 | Long-term depression_Homo sapiens_hsa04730 | 0.19129121 |
| 139 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18244991 |
| 140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17578165 |
| 141 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17077755 |
| 142 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.16825368 |

